Low-dose estradiol gel 0.1% for the treatment of vasomotor symptoms associated with menopause

References

• Gold EB, Sternfeld B, Kelsey JL et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am. J. Epidemiol.152, 463–473 (2000).
   PubMed Web of Science ®Google Scholar
• Kronenberg F. Hot flushes: epidemiology and physiology. Ann. NY Acad. Sci.592, 52–86 (1990).
   PubMed Web of Science ®Google Scholar
• Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil. Steril.75(6), 1065–1079 (2001).
   PubMed Web of Science ®Google Scholar
• Notelovitz M, Lenihan JP, McDermott M et al. Initial 17β-estradiol dose for treating vasomotor symptoms. Obstet. Gynecol.95(5), 726–731 (2000).
   PubMed Web of Science ®Google Scholar
• Al-Azzawi F, Buckler HM; United Kingdom Vaginal Ring Investigator Group. Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms. Climacteric6(2), 118–127 (2003).
   PubMed Web of Science ®Google Scholar
• Utian WH, Burry KA, Archer DF et al. Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. The Esclim Study Group. Am. J. Obstet. Gynecol.181(1), 71–79 (1999).
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N. Engl. J. Med.325(11), 756–762 (1991).
   PubMed Web of Science ®Google Scholar
• Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann. Intern. Med.140, 184–188 (2004).
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA288(3), 321–333 (2002).
   PubMed Web of Science ®Google Scholar
• Manson JE, Hsia J, Johnson KC et al. Estrogen plus progestin and the risk of coronary heart disease. N. Engl. J. Med.349(6), 523–534 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA291(14), 1701–1712 (2004).
   PubMed Web of Science ®Google Scholar
• Stephenson J. FDA orders estrogen safety warnings: agency offers guidance for HRT use. JAMA289, 537–538 (2003).
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Women’s Health Care Physicians. Hormone therapy. Obstet. Gynecol.104(Suppl. 4) S1–S4 (2004).
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. Recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause11, 589–600 (2004).
   Google Scholar
• Willhite LA, O’Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy21, 464–480 (2001).
   PubMed Web of Science ®Google Scholar
• Minkin MJ. Considerations in the choice of oral vs. transdermal hormone therapy: a review. J. Reprod. Med.49, 311–320 (2004).
   PubMed Web of Science ®Google Scholar
• Ansbacher R. The pharmacokinetics and efficacy of different estrogens are not equivalent. Am. J. Obstet. Gynecol.184, 255–263 (2001).
   PubMed Web of Science ®Google Scholar
• Canonico M, Oger E, Plu-Bureau G et al. Estrogen and Thromboembolism Risk (ESTHER) Study Group, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation115(7), 840–845 (2007).
   PubMed Web of Science ®Google Scholar
• Post MS, Christella M, Thomassen LG et al. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women. Arterioscler. Thromb. Vasc. Biol.23(6), 1116–1121 (2003).
   PubMed Web of Science ®Google Scholar
• Oger E, Alhenc-Gelas M, Lacut K et al. Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. Arterioscler. Thromb. Vasc. Biol.23(9), 1671–1676 (2003).
   PubMed Web of Science ®Google Scholar
• Scarabin PY, Alhenc-Gelas M, Plu-Bureau G et al. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler. Thromb. Vasc. Biol.17(11), 3071–3078 (1997).
   PubMed Web of Science ®Google Scholar
• Järvinen A, Granander M, Nykänen S, Laine T, Geurts P, Viitanen A. Steady-state pharmacokinetics of oestradiol gel in postmenopausal women: effects of application area and washing. Br. J. Obstet. Gynaecol.104(Suppl. 16), 14–18 (1997).
   Google Scholar
• Lambrecht LJ, Harris KA, Halvorsen MB. Pharmacokinetic properties of estradiol gel 0.1%. Presented at: The 18th Annual Meeting of the North American Menopause Society. Dallas, TX, USA, 3–6 October 2007.
   Google Scholar
• Naunton, M, Al Hadithy A, Brouwers J, Archer D. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women. Menopause13 (3), 517–527 (2006).
   PubMed Web of Science ®Google Scholar
• Longcope C. Hormone dynamics at the menopause. Ann. NY Acad. Sci.592, 21–30 (1990).
   PubMed Web of Science ®Google Scholar
• Divigel® insert. Upsher–Smith Laboratories, Inc., MN, USA (2007).
   Google Scholar
• Ackerman R, Hedrick RE Jr, Lambrecht LJ. Efficacy of 3 doses of estradiol gel 0.1% in the treatment of vasomotor symptoms and vulvar vaginal atrophy. Presented at: The 18th Annual Meeting of the North American Menopause Society. Dallas, TX, USA, 3–6 October 2007.
   Google Scholar
• Hirvonen E, Crona N, Wahlstrom T, Backstrom AC. Effect of an estradiol gel with monthly or quarterly progestogen on menopausal symptoms and bleeding. Climacteric3(4), 262–270 (2000).
   PubMedGoogle Scholar
• Hirvonen E, Lamberg-Allardt C, Lankinen KS, Geurts P, Wilen-Rosenqvist G. Transdermal oestradiol gel in the treatment of the climacterium: a comparison with oral therapy. Br. J. Obstet. Gynaecol.104(Suppl. 16), 19–25 (1997).
   PubMedGoogle Scholar
• Hirvonen E, Cacciatore B, Wahlstrom T, Rita H, Wilen-Rosenqvist G. Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch. Br. J. Obstet. Gynaecol.104(Suppl. 16), 26–31 (1997).
   PubMedGoogle Scholar
• Ackerman R, Koltun W, Lambrecht, LJ. Safety and tolerability of 3 doses of estradiol gel 0.1% in the treatment of menopausal symptoms. Presented at: The 18th Annual Meeting of the North American Menopause Society. October 3–6, 2007, Dallas, TX.
   Google Scholar
• Rossouw JE, Prentice RL, Manson JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA297, 1465–1477 (2007).
   PubMed Web of Science ®Google Scholar
• Manson JE, Allison MA, Rossouw JE et al. Estrogen therapy and coronary-artery calcification. N. Engl. J. Med.356, 2591–2602 (2007).
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause14(2), 168–182 (2007).
   PubMed Web of Science ®Google Scholar
• Board of the International Menopause Society. IMS updated recommendations on postmenopausal hormone therapy. Climacteric10(3), 181–194 (2007).
   Google Scholar
• Harman SM, Brinton EA, Cedars M et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric8, 3–12 (2005).
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society. Menopause Practice: a Clinician’s Guide (3rd Edition). The North American Menopause Society, OH, USA (2004).
   Google Scholar